BACPHARPharmaceuticals
Bacil Pharma Ltd — Cash Flow Statement
₹47.73
-1.10%
Bacil Pharma Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.40 Cr | -29000.00 | -0.15 Cr | -4.01 Cr | — |
| Issuance Of Capital Stock | 2.76 Cr | — | — | — | — |
| End Cash Position | 2.86 Cr | 0.04 Cr | 0.03 Cr | 0.23 Cr | — |
| Beginning Cash Position | 0.04 Cr | 0.03 Cr | 0.23 Cr | 0.10 Cr | — |
| Changes In Cash | 2.82 Cr | 0.01 Cr | -0.20 Cr | 0.13 Cr | — |
| Financing Cash Flow | 2.08 Cr | -0.06 Cr | 0.06 Cr | 0.33 Cr | — |
| Net Preferred Stock Issuance | 2.76 Cr | — | — | — | — |
| Preferred Stock Issuance | 2.76 Cr | — | — | — | — |
| Net Issuance Payments Of Debt | -0.68 Cr | -0.06 Cr | 0.06 Cr | 0.33 Cr | — |
| Net Short Term Debt Issuance | -0.68 Cr | -0.06 Cr | 0.06 Cr | 0.33 Cr | — |
| Investing Cash Flow | 0.34 Cr | 0.08 Cr | -0.12 Cr | 3.81 Cr | — |
| Interest Received Cfi | 0.03 Cr | 0.03 Cr | 0.03 Cr | 0.06 Cr | — |
| Net Investment Purchase And Sale | 0.31 Cr | 0.05 Cr | -0.15 Cr | 3.75 Cr | — |
| Operating Cash Flow | 0.40 Cr | -29000.00 | -0.15 Cr | -4.01 Cr | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | 0.02 Cr | 0.08 Cr | -0.02 Cr | -0.10 Cr | — |
| Change In Other Current Liabilities | 0.06 Cr | 0.08 Cr | -0.01 Cr | -0.14 Cr | — |
| Change In Other Current Assets | -0.04 Cr | -15000.00 | 5000.00 | 0.05 Cr | — |
| Change In Payable | 5000.00 | 32000.00 | -0.01 Cr | -4402.00 | — |
| Other Non Cash Items | -0.03 Cr | -0.03 Cr | -0.03 Cr | -0.06 Cr | — |
| Depreciation And Amortization | 7000.00 | 20000.00 | 27000.00 | 37174.00 | — |
| Depreciation | 7000.00 | 20000.00 | 27000.00 | 37174.00 | — |
| Gain Loss On Sale Of PPE | 55000.00 | 0.00 | — | — | — |
| Net Income From Continuing Operations | 0.41 Cr | -0.06 Cr | -0.10 Cr | -3.86 Cr | — |
| Net Long Term Debt Issuance | — | -0.06 Cr | 0.06 Cr | 0.33 Cr | -0.07 Cr |
| Net Other Investing Changes | — | 1000.00 | — | — | — |
| Net PPE Purchase And Sale | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase Of PPE | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Receivables | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | 1000.00 | -1000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bacil Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.